Please enable JavaScript to continue using this application.

Compare $FBIO vs $OSTX | Chartloom

Compare

$FBIO vs $OSTX

Fortress Biotech Inc · OS Therapies Inc

FBIO

Fortress Biotech Inc

OSTX

OS Therapies Inc

Compare $FBIO vs $OSTX

Comparing Fortress Biotech Inc and OS Therapies Inc

FBIOFortress Biotech Inc

OSTXOS Therapies Inc

FBIOFortress Biotech Inc

Market cap

$71M

P/E (TTM)

0.66x

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

15.5%

YTD performance

-47.0%

52W performance

-26.6%

FCF yield

1.8%

OSTXOS Therapies Inc

Market cap

$74M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

20.9%

52W performance

-20.6%

FCF yield

-25.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

FBIO

OSTX

Detailed metrics comparison

FBIO

Fortress Biotech Inc

OSTX

OS Therapies Inc

Market Cap

FBIO$71M

OSTX$74M

Enterprise Value

FBIO$-86M

OSTX$74M

Price

FBIO$2.14

OSTX$1.62

P/E Ratio

FBIO0.66x

OSTXN/A

P/S Ratio

FBIO1.04x

OSTX0.00x

EV/Sales

FBIO-1.26x

OSTX0.00x

EV/EBITDA

FBIO0.00x

OSTX0.00x

P/B Ratio

FBIO0.41x

OSTX16.11x

P/FCF Ratio

FBIO0.56x

OSTXN/A

EV/FCF

FBIO-0.68x

OSTX-3.97x

PEG Ratio

FBION/A

OSTXN/A

Forward P/E (NTM)

FBION/A

OSTXN/A

Forward P/S (NTM)

FBION/A

OSTXN/A

Revenue (TTM)

FBIO$68M

OSTX$0

Revenue Growth (YoY)

FBIO15.5%

OSTXN/A

Forward Rev Growth

FBIO43.7%

OSTX534.8%

Gross Margin (TTM)

FBIO65.6%

OSTX0.0%

Operating Margin (TTM)

FBIO0.0%

OSTX0.0%

EBITDA Margin (TTM)

FBIO-36.1%

OSTX0.0%

Net Margin (TTM)

FBIO151.0%

OSTX0.0%

FCF Margin (TTM)

FBIO183.8%

OSTXN/A

Net Income (TTM)

FBIO$103M

OSTX$-39M

FCF (TTM)

FBIO$126M

OSTX$-19M

EPS (TTM)

FBIO$3.25

OSTX-$0.90

ROE (TTM)

FBIO103.5%

OSTX-56759.0%

ROA (TTM)

FBIO43.0%

OSTX-47736.0%

ROIC (TTM)

FBIO71.7%

OSTX-56759.0%

Cash

FBIO$197M

OSTX$205K

Debt

FBIO$40M

OSTX$0

Net Cash/Debt

FBIO$157M

OSTX$205K

Current Ratio (TTM)

FBIO3.96x

OSTX0.18x

Quick Ratio (TTM)

FBIO3.76x

OSTX0.16x

Debt/Equity (TTM)

FBIO0.24x

OSTX0.00x

Debt/Assets (TTM)

FBIO0.0%

OSTX0.0%

Interest Coverage (TTM)

FBION/A

OSTXN/A

Net Debt/EBITDA (TTM)

FBIO0.00x

OSTX0.00x

Beta

FBIO1.23

OSTX1.36

52W Performance

FBIO-26.6%

OSTX-20.6%

YTD Performance

FBIO-47.0%

OSTX20.9%

% from 52W High

FBIO-52.9%

OSTX-28.0%

% from 52W Low

FBIO6.7%

OSTX40.9%

Asset Turnover (TTM)

FBIO0.26x

OSTX0.00x

FCF Yield (TTM)

FBIO1.8%

OSTX-25.1%

Earnings Yield (TTM)

FBIO145.7%

OSTX-53.4%

Dividend Yield (TTM)

FBIO0.7%

OSTXN/A

Rule of 40

FBIO199.3

OSTX0.0

EV/GP/RG

FBION/A

OSTXN/A

Ticker research

View FBIO research View OSTX research

Metric	FBIO Fortress Biotech Inc	OSTX OS Therapies Inc
Market & Valuation
Market Cap	$71M	$74M
Enterprise Value	$-86M	$74M
Price	$2.14	$1.62
P/E Ratio	0.66x	N/A
P/S Ratio	1.04x	0.00x
EV/Sales	-1.26x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.41x	16.11x
P/FCF Ratio	0.56x	N/A
EV/FCF	-0.68x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$0
Revenue Growth (YoY)	15.5%	N/A
Forward Rev Growth	43.7%	534.8%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-36.1%	0.0%
Net Margin (TTM)	151.0%	0.0%
FCF Margin (TTM)	183.8%	N/A
Net Income (TTM)	$103M	$-39M
FCF (TTM)	$126M	$-19M
EPS (TTM)	$3.25	-$0.90
ROE (TTM)	103.5%	-56759.0%
ROA (TTM)	43.0%	-47736.0%
ROIC (TTM)	71.7%	-56759.0%
Financial Health
Cash	$197M	$205K
Debt	$40M	$0
Net Cash/Debt	$157M	$205K
Current Ratio (TTM)	3.96x	0.18x
Quick Ratio (TTM)	3.76x	0.16x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.36
52W Performance	-26.6%	-20.6%
YTD Performance	-47.0%	20.9%
% from 52W High	-52.9%	-28.0%
% from 52W Low	6.7%	40.9%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.00x
FCF Yield (TTM)	1.8%	-25.1%
Earnings Yield (TTM)	145.7%	-53.4%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View OSTX research

Valuation

P/E Ratio

FBIO

0.66x

P/S Ratio

OSTX

0.00x

FBIO

1.04x

EV/FCF

OSTX

-3.97x

FBIO

-0.68x

Growth & revenue

Revenue Growth TTM

FBIO

15.5%

Forward Revenue Growth

OSTX

534.8%

FBIO

43.7%

Profitability & performance

Gross Margin

FBIO

65.6%

OSTX

0.0%

ROE

FBIO

103.5%

OSTX

-56759.0%

FCF Yield %

FBIO

1.8%

OSTX

-25.1%

52-Week Performance

OSTX

-20.6%

FBIO

-26.6%

Detailed metrics comparison

FBIO

Fortress Biotech Inc

OSTX

OS Therapies Inc

Market Cap

FBIO$71M

OSTX$74M

Enterprise Value

FBIO$-86M

OSTX$74M

Price

FBIO$2.14

OSTX$1.62

P/E Ratio

FBIO0.66x

OSTXN/A

P/S Ratio

FBIO1.04x

OSTX0.00x

EV/Sales

FBIO-1.26x

OSTX0.00x

EV/EBITDA

FBIO0.00x

OSTX0.00x

P/B Ratio

FBIO0.41x

OSTX16.11x

P/FCF Ratio

FBIO0.56x

OSTXN/A

EV/FCF

FBIO-0.68x

OSTX-3.97x

PEG Ratio

FBION/A

OSTXN/A

Forward P/E (NTM)

FBION/A

OSTXN/A

Forward P/S (NTM)

FBION/A

OSTXN/A

Revenue (TTM)

FBIO$68M

OSTX$0

Revenue Growth (YoY)

FBIO15.5%

OSTXN/A

Forward Rev Growth

FBIO43.7%

OSTX534.8%

Gross Margin (TTM)

FBIO65.6%

OSTX0.0%

Operating Margin (TTM)

FBIO0.0%

OSTX0.0%

EBITDA Margin (TTM)

FBIO-36.1%

OSTX0.0%

Net Margin (TTM)

FBIO151.0%

OSTX0.0%

FCF Margin (TTM)

FBIO183.8%

OSTXN/A

Net Income (TTM)

FBIO$103M

OSTX$-39M

FCF (TTM)

FBIO$126M

OSTX$-19M

EPS (TTM)

FBIO$3.25

OSTX-$0.90

ROE (TTM)

FBIO103.5%

OSTX-56759.0%

ROA (TTM)

FBIO43.0%

OSTX-47736.0%

ROIC (TTM)

FBIO71.7%

OSTX-56759.0%

Cash

FBIO$197M

OSTX$205K

Debt

FBIO$40M

OSTX$0

Net Cash/Debt

FBIO$157M

OSTX$205K

Current Ratio (TTM)

FBIO3.96x

OSTX0.18x

Quick Ratio (TTM)

FBIO3.76x

OSTX0.16x

Debt/Equity (TTM)

FBIO0.24x

OSTX0.00x

Debt/Assets (TTM)

FBIO0.0%

OSTX0.0%

Interest Coverage (TTM)

FBION/A

OSTXN/A

Net Debt/EBITDA (TTM)

FBIO0.00x

OSTX0.00x

Beta

FBIO1.23

OSTX1.36

52W Performance

FBIO-26.6%

OSTX-20.6%

YTD Performance

FBIO-47.0%

OSTX20.9%

% from 52W High

FBIO-52.9%

OSTX-28.0%

% from 52W Low

FBIO6.7%

OSTX40.9%

Asset Turnover (TTM)

FBIO0.26x

OSTX0.00x

FCF Yield (TTM)

FBIO1.8%

OSTX-25.1%

Earnings Yield (TTM)

FBIO145.7%

OSTX-53.4%

Dividend Yield (TTM)

FBIO0.7%

OSTXN/A

Rule of 40

FBIO199.3

OSTX0.0

EV/GP/RG

FBION/A

OSTXN/A

Ticker research

View FBIO research View OSTX research

Metric	FBIO Fortress Biotech Inc	OSTX OS Therapies Inc
Market & Valuation
Market Cap	$71M	$74M
Enterprise Value	$-86M	$74M
Price	$2.14	$1.62
P/E Ratio	0.66x	N/A
P/S Ratio	1.04x	0.00x
EV/Sales	-1.26x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.41x	16.11x
P/FCF Ratio	0.56x	N/A
EV/FCF	-0.68x	-3.97x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$68M	$0
Revenue Growth (YoY)	15.5%	N/A
Forward Rev Growth	43.7%	534.8%
Profitability
Gross Margin (TTM)	65.6%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-36.1%	0.0%
Net Margin (TTM)	151.0%	0.0%
FCF Margin (TTM)	183.8%	N/A
Net Income (TTM)	$103M	$-39M
FCF (TTM)	$126M	$-19M
EPS (TTM)	$3.25	-$0.90
ROE (TTM)	103.5%	-56759.0%
ROA (TTM)	43.0%	-47736.0%
ROIC (TTM)	71.7%	-56759.0%
Financial Health
Cash	$197M	$205K
Debt	$40M	$0
Net Cash/Debt	$157M	$205K
Current Ratio (TTM)	3.96x	0.18x
Quick Ratio (TTM)	3.76x	0.16x
Debt/Equity (TTM)	0.24x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.23	1.36
52W Performance	-26.6%	-20.6%
YTD Performance	-47.0%	20.9%
% from 52W High	-52.9%	-28.0%
% from 52W Low	6.7%	40.9%
Efficiency & Yields
Asset Turnover (TTM)	0.26x	0.00x
FCF Yield (TTM)	1.8%	-25.1%
Earnings Yield (TTM)	145.7%	-53.4%
Dividend Yield (TTM)	0.7%	N/A
Other
Rule of 40	199.3	0.0
EV/GP/RG	N/A	N/A
Ticker research	View FBIO research	View OSTX research